Bio-Medical Applications Of Pennsylvania Inc is categorized under Kidney Dialysis Centers in Palmyra, PA .
Bio-Medical Applications Of Pennsylvania Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 621492 by the NAICS.
If you are seeking more information, feel free to contact Jim Barsanti at the company’s branch by writing to 38-42 Londonderry Avenue, Palmyra, Pennsylvania PA 17078 or by phoning (717) 838-6050. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bio-Medical Applications Of Pennsylvania Inc |
| Contact Person: | Jim Barsanti |
| Address: | 38-42 Londonderry Avenue, Palmyra, Pennsylvania 17078 |
| Phone Number: | (717) 838-6050 |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Kidney Dialysis Centers |
| SIC Code: | 8092 |
| NAICS Code: | 621492 |
| Share This Business: |
Bio-Medical Applications Of Pennsylvania Inc was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 621492. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Jim Barsanti for inquiries that concern Bio-Medical Applications Of Pennsylvania Inc by calling the company number (717) 838-6050, as your correspondence is most welcome. Additionally, the physical location of the branch of Bio-Medical Applications Of Pennsylvania Inc can be found at the coordinates 40.300404,-76.578377 as well as the street address 38-42 Londonderry Avenue in Palmyra, Pennsylvania 17078.
For its online presence, you may visit Bio-Medical Applications Of Pennsylvania Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.